Investments
417Portfolio Exits
93Funds
10Partners & Customers
10Service Providers
1About Flagship Pioneering
Flagship Pioneering operates as a biotechnology company focused on inventing platforms and building companies that aim to transform human health and sustainability. The company's main offerings include the creation of scientific ventures and the development of platforms that lead to innovative products in the fields of human health and agriculture. Flagship Pioneering's ecosystem consists of over 40 companies, indicating a broad engagement with various sectors within the biotechnology industry. It was founded in 2000 and is based in Cambridge, Massachusetts.
Expert Collections containing Flagship Pioneering
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Flagship Pioneering in 4 Expert Collections, including Vitamin & Supplement Startups.
Vitamin & Supplement Startups
237 items
Synthetic Biology
382 items
Game Changers 2018
20 items
CB Insights Healthcare Smart Money Investors - 2020
25 items
Track the world's top-performing VC investors in healthcare. Firms are presented in alphabetical order.
Latest Flagship Pioneering News
Oct 24, 2024
Europe Correspondent LONDON — A coworking space surrounded by the crush of traffic around King’s Cross station is perhaps not the most glamorous digs. But as the site of Flagship Pioneering’s U.K. outpost, it fits. Not far are University College London, the Wellcome Trust, and the Francis Crick Institute. Novo Nordisk and Merck have major hubs nearby, as do Meta and Google. advertisement Flagship, the high-profile venture firm, opened its U.K. office last year, and also unveiled Quotient Therapeutics , a biotech split between Cambridge, Mass., and Cambridge, England. But it was only last month that Junaid Bajwa, the head of Flagship’s U.K. efforts, officially started. STAT+ Exclusive Story
Flagship Pioneering Investments
417 Investments
Flagship Pioneering has made 417 investments. Their latest investment was in Mirai Bio as part of their Series A on September 26, 2024.
Flagship Pioneering Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
9/26/2024 | Series A | Mirai Bio | $50M | Yes | 2 | |
7/23/2024 | Series A | Abiologics | $50M | Yes | 4 | |
5/7/2024 | Series A | Prologue Medicines | $50M | Yes | 3 | |
1/30/2024 | Series F | |||||
12/29/2023 | Series C |
Date | 9/26/2024 | 7/23/2024 | 5/7/2024 | 1/30/2024 | 12/29/2023 |
|---|---|---|---|---|---|
Round | Series A | Series A | Series A | Series F | Series C |
Company | Mirai Bio | Abiologics | Prologue Medicines | ||
Amount | $50M | $50M | $50M | ||
New? | Yes | Yes | Yes | ||
Co-Investors | |||||
Sources | 2 | 4 | 3 |
Flagship Pioneering Portfolio Exits
93 Portfolio Exits
Flagship Pioneering has 93 portfolio exits. Their latest portfolio exit was Prologue Medicines on May 06, 2024.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
5/6/2024 | Spinoff / Spinout | 1 | |||
10/19/2023 | Merger | 1 | |||
10/19/2023 | Merger | 3 | |||
Date | 5/6/2024 | 10/19/2023 | 10/19/2023 | ||
|---|---|---|---|---|---|
Exit | Spinoff / Spinout | Merger | Merger | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 1 | 1 | 3 |
Flagship Pioneering Fund History
10 Fund Histories
Flagship Pioneering has 10 funds, including Flagship Pioneering Fund VIII.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
7/7/2024 | Flagship Pioneering Fund VIII | $52.2M | 3 | ||
6/14/2021 | Flagship Pioneering - Origination Fund VII | $3,400M | 3 | ||
3/20/2019 | Flagship Pioneering Special Opportunities Fund II | Multi-Stage Venture Capital | Closed | $824M | 8 |
12/20/2017 | Flagship Pioneering Fund VI | ||||
12/15/2016 | Flagship Ventures Opportunities Fund I |
Closing Date | 7/7/2024 | 6/14/2021 | 3/20/2019 | 12/20/2017 | 12/15/2016 |
|---|---|---|---|---|---|
Fund | Flagship Pioneering Fund VIII | Flagship Pioneering - Origination Fund VII | Flagship Pioneering Special Opportunities Fund II | Flagship Pioneering Fund VI | Flagship Ventures Opportunities Fund I |
Fund Type | Multi-Stage Venture Capital | ||||
Status | Closed | ||||
Amount | $52.2M | $3,400M | $824M | ||
Sources | 3 | 3 | 8 |
Flagship Pioneering Partners & Customers
10 Partners and customers
Flagship Pioneering has 10 strategic partners and customers. Flagship Pioneering recently partnered with Pfizer on August 8, 2024.
Date | Type | Business Partner | Country | News Snippet | Sources |
|---|---|---|---|---|---|
8/28/2024 | Partner | United States | Agreement initiated under strategic partnership between Flagship Pioneering and Pfizer Inc | 3 | |
7/29/2024 | Partner | United States | GSK, Flagship Pioneering Commit $150M to Start R&D Pact for Novel Drugs and Vaccines The partnership comes a little more than a year after Pfizer and Flagship Pioneering began an alliance . | 1 | |
7/29/2024 | Licensee | United Kingdom | GSK partners with Flagship Pioneering to develop medicines and vaccines Recently , the company has been entering into a series of partnerships with biotech companies , including one with Pfizer last year to create a new pipeline of innovative medicines , while Metaphore Biotechnologies , one of Flagship Pioneering 's companies , partnered with Novo Nordisk in May to develop up to two therapeutics for obesity management . | 2 | |
7/29/2024 | Licensee | ||||
7/25/2024 | Partner |
Date | 8/28/2024 | 7/29/2024 | 7/29/2024 | 7/29/2024 | 7/25/2024 |
|---|---|---|---|---|---|
Type | Partner | Partner | Licensee | Licensee | Partner |
Business Partner | |||||
Country | United States | United States | United Kingdom | ||
News Snippet | Agreement initiated under strategic partnership between Flagship Pioneering and Pfizer Inc | GSK, Flagship Pioneering Commit $150M to Start R&D Pact for Novel Drugs and Vaccines The partnership comes a little more than a year after Pfizer and Flagship Pioneering began an alliance . | GSK partners with Flagship Pioneering to develop medicines and vaccines Recently , the company has been entering into a series of partnerships with biotech companies , including one with Pfizer last year to create a new pipeline of innovative medicines , while Metaphore Biotechnologies , one of Flagship Pioneering 's companies , partnered with Novo Nordisk in May to develop up to two therapeutics for obesity management . | ||
Sources | 3 | 1 | 2 |
Flagship Pioneering Service Providers
1 Service Provider
Flagship Pioneering has 1 service provider relationship
Service Provider | Associated Rounds | Provider Type | Service Type |
|---|---|---|---|
Counsel | General Counsel |
Service Provider | |
|---|---|
Associated Rounds | |
Provider Type | Counsel |
Service Type | General Counsel |
Partnership data by VentureSource
Flagship Pioneering Team
38 Team Members
Flagship Pioneering has 38 team members, including current Founder, Chief Executive Officer, Noubar Afeyan.
Name | Work History | Title | Status |
|---|---|---|---|
Noubar Afeyan | Montai Health, Sana Biotechnology, Ring Therapeutics, Cellarity, Laronde, Omega Therapeutics, Repertoire Immune Medicines, Cygnal Therapeutics, Kaleido Biosciences, Evelo Biosciences, CiBO Technologies, Codiak Biosciences, Rubius Therapeutics, Seres Therapeutics, Axcella Health, Joule Unlimited, LS9, Codon Devices, Helicos BioSciences, Adnexus Therapeutics, Epitome Biosystems, Ensemble Therapeutics, Affinnova, Selventa, Bg Medicine, MIT Sloan, Celera Genomics, ChemGenics Pharmaceuticals, and Perseptive Biosystems | Founder, Chief Executive Officer | Current |
Name | Noubar Afeyan | ||||
|---|---|---|---|---|---|
Work History | Montai Health, Sana Biotechnology, Ring Therapeutics, Cellarity, Laronde, Omega Therapeutics, Repertoire Immune Medicines, Cygnal Therapeutics, Kaleido Biosciences, Evelo Biosciences, CiBO Technologies, Codiak Biosciences, Rubius Therapeutics, Seres Therapeutics, Axcella Health, Joule Unlimited, LS9, Codon Devices, Helicos BioSciences, Adnexus Therapeutics, Epitome Biosystems, Ensemble Therapeutics, Affinnova, Selventa, Bg Medicine, MIT Sloan, Celera Genomics, ChemGenics Pharmaceuticals, and Perseptive Biosystems | ||||
Title | Founder, Chief Executive Officer | ||||
Status | Current |
Loading...